Prophylactic antibiotic treatment with TMPSMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy

Several studies have reported the incidence of interstitial pneumonia (IP) among patients with nonHodgkin lymphoma (NHL) that are undergoing combination chemotherapy plus rituximab; however, the effective prophylactic treatment for IP remains unclear.